Furthermore, our results suggest that biologics, such as anti-IgE antibodies, which have shown efficacy in ABPA and have fewer side effects, including a lower risk of infections than corticosteroids [26], may also be beneficial for this subgroup. This evidence concerns the gene IGHE and infection.